Dr. Carmelita G. Frondoza Joins Nutramax Laboratories, Inc. as Director of Research and Development

EDGEWOOD, Md., Sep 21, 2005 (BUSINESS WIRE) -- Nutramax Laboratories, Inc. announces that Carmelita G. Frondoza, PhD, has been named to head its research and development organization.

"Dr. Frondoza epitomizes our commitment to state of the art, scientific research and quality standards related to product development. She will lead a team of skilled scientists including molecular and cell biologists as well as protein chemists. We're proud to have her join our company," notes Nutramax Laboratories, Inc. President, Dr. Bob Henderson.

A Hopkins graduate with a PhD in Immunology and Postdoctoral Fellow in Oncology, Dr. Frondoza has been involved in the study of nutraceuticals for Johns Hopkins University for the past seven years. She was a recipient of NIH funding through the Center of Complementary-Alternative Medicine and has worked with regulatory agencies in the development of product guidelines and specifications. In addition, she has published numerous articles, papers and has served as a peer review editor for leading industry journals.

At Nutramax Laboratories, Inc. Dr. Frondoza will be responsible for guiding the company's team in research and development for defining new products and refining current products. She says of her new position, "I decided to join Nutramax Laboratories, Inc. because I am excited at the prospect of bringing cutting edge science-based technology and methodology for the discovery and development of products at Nutramax Laboratories, Inc."

About Nutramax Laboratories, Inc.: Nutramax Laboratories, Inc. researches, develops, and markets products to support the active lifestyles of people and animals. The corporate entity has two business divisions: Consumer Products and Veterinary Science.

Nutramax Laboratories, Inc. Consumer Products Division markets Cosamin(R)DS joint health supplement, the #1 recommended glucosamine/chondroitin sulfate brand by Orthopedic Surgeons and Rheumatologists(1). CosaminDS formula includes the exclusive low molecular weight chondroitin sulfate selected for inclusion by the National Institutes of Health (NIH) GAIT study. The Consumer Products Division also markets Senior Moment(R) used to support brain function, and CoMaxQ10(R), an antioxidant.

Nutramax Laboratories Veterinary Science Division markets Cosequin(R), the #1 veterinarian-recommended joint health supplement brand(2), and also markets Denosyl(R) and Marin(TM) for support of liver function; Welactin(TM), to help support dogs and cats' overall wellness during the aging process; Consil(R) Dental synthetic bone graft particulate for use in dental procedures, including extraction sites; and Consil(R) Orthopedic, specially packaged with a dual sterile barrier for use in orthopedic procedures.

For more information about Nutramax Laboratories Inc., visit www.nutramaxlabs.com.

(1) SLACK Incorporated Market Research Survey, June, 2005, July 2003, November 2001 and April 2000. Surveys conducted of Orthopedic Surgeons & Rheumatologists relating to glucosamine/chondroitin sulfate brands

(2) Surveys conducted in October 2001 and March 2004 of small animal veterinarians who recommended oral joint health supplements. Surveys conducted in the Fall of 2002 and March 2004 of equine veterinarians who recommended oral joint health supplements.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.